Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-013701

Chief Development Officer sold 238 shares at $10.71 ($2,549)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer Chief Development Officer 2023-04-18 Sale −238 $10.71 $2,549 90,879 D
Open-market sales · 238 sh · avg $10.71 · $2,549
Loading xslF345X04/ownership.xml…